Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of the Role of 18F-FSPG PET/CT Imaging for Cancer Patients Receiving Therapy

NCT02599194 is registered in ClinicalTrials.gov with Andrei Iagaru as lead sponsor.

NCT NCT02599194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02599194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of the Role of 18F-FSPG PET/CT Imaging for Cancer Patients Receiving Therapy
Lead sponsor
Andrei Iagaru
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2015
Completion date
December 14, 2016
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell neoplasm, estrogen receptor negative, her2/neu negative, metastatic renal cell cancer, progesterone receptor negative, stage iii mesothelioma, stage iii renal cell cancer, stage iiia breast cancer, stage iiia non-small cell lung cancer, stage iiib non-small cell lung cancer, stage iiic breast cancer, stage iv breast cancer, stage iv mesothelioma, stage iv non-small cell lung cancer, stage iv renal cell cancer, triple-negative breast carcinoma